|Former Common name||BALB-Nh|
|H-2 Haplotype||No Data|
|Background strain||No Data|
|Strain development||Developed by Shionogi & Co., Ltd.. Arose in DS mouse that has been established as an inbred strain from a dd closed colony mice.|
|Strain description||Non-hair dominant spontaneous mutant mice arose in DS/Shi inbred souse strain. A G1717A point mutation has been found in the Trpv3, which results in Gly 573 being replaced with Ser. Coisogenic strain (RBRC06233), C57BL/6J (C57BL/6JShi) congenic (RBRC06234) and BALB/c (BALB/cMsShi) congenic (RBRC06235).|
|Colony maintenance||Wild-type (female) x Heterozygote (male)|
|Health Report||No Data|
|Symbol name||transient receptor potential cation channel, subfamily V, member 3|
|Common name||No Data|
|Symbol description||No Data|
|Research applications||Immunology and Inflammation Research,
Mouse Models for Human Disease
|Specific Term and Conditions||The following terms and conditions will be requested by the DEPOSITOR.
1) In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. 2) The RECIPIENT must inform the DEPOSITOR the research plan using the BIOLOGICAL RESOURCE and must obtain a prior written consent form the DEPOSITOR using the APPROVAL FORM specified by the DEPOSITOR. 3) The RECIPIENT shall use the BIOLOGICAL RESOURCE exclusively for the purpose of research which was written in the research plan. 4) In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, the RECIPIENT must inform the DEPOSITOR of the contents of such publication in advance. 5) The RECIPIENT contact and discuss with the DEPOSITOR in case of filing a patent application based on research results by using the BIOLOGICAL RESOURCES. 6) The RECIPIENT must contact and discuss with the DEPOSITOR in case of application for any commercial use.
|Depositor||Yasui, Kiyoshi (Shionogi & Co., Ltd.)|
|Strain Status /